Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma
Vadim Ivanov(Hôpital de la Conception), Régis Costello(Inserm), Raphaëlle Fanciullino(Inserm), Isabelle Arnoux(Johannes Gutenberg University Mainz), Corinne Nicolino‐Brunet(Hôpital de la Conception), Laure Farnault(Aix-Marseille Université), Geoffroy Venton(Inserm), Julien Colle(Inserm), Hubert Lépidi(Centre National de la Recherche Scientifique), C. Colavolpe(Hôpital de la Timone), Gleb S. Ivanov(Surrey and Sussex Healthcare NHS Trust), Cédric Mercier(Inserm), Yaël Berda‐Haddad(Assistance Publique Hôpitaux de Marseille)
Cited by 0
Related Papers
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
|Journal of the American Heart Association|2020|298
Molecular Diagnosis of Infective Endocarditis by PCR Amplification and Direct Sequencing of DNA from Valve Tissue
|Journal of Clinical Microbiology|2003|184
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
|Blood|2021|157
Metformin reverses early cortical network dysfunction and behavior changes in Huntington’s disease
|eLife|2018|124
Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?
|European Journal of Nuclear Medicine and Molecular Imaging|2008|100